US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
JPS58403B2
(en)
|
1975-07-24 |
1983-01-06 |
武田薬品工業株式会社 |
L- Ascorbine Sanseizaino Seizouhou
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
US5135757A
(en)
|
1988-09-19 |
1992-08-04 |
Edward Mendell Co., Inc. |
Compressible sustained release solid dosage forms
|
IT1229203B
(en)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS.
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
FR2704146B1
(en)
|
1993-04-19 |
1995-07-13 |
Cripdom |
Microcapsules of acetylsalicylic acid with controlled release.
|
US5773025A
(en)
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
IT1270594B
(en)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN
|
FR2725623A1
(en)
|
1994-10-18 |
1996-04-19 |
Flamel Tech Sa |
MEDICINAL AND / OR NUTRITION MICROCAPSULES FOR PER OS ADMINISTRATION
|
KR100891756B1
(en)
|
1997-04-15 |
2009-04-07 |
씨에스아이알 |
Pharmaceutical compositions having appetite suppressant activity
|
US5891919A
(en)
|
1997-09-19 |
1999-04-06 |
Burlington Bio-Medical & Scientific Corp. |
Denatonium capsaicinate and methods of producing the same
|
US6180365B1
(en)
|
1998-11-06 |
2001-01-30 |
Smithkline Beecham Corporation |
Polynucleotide encoding a Mouse 7-transmembrane GPR43 receptor
|
ITMI991316A1
(en)
|
1999-06-14 |
2000-12-14 |
Cip Ninety Two 92 S A |
ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF MESALAZINE
|
IL132313A0
(en)
|
1999-10-11 |
2001-03-19 |
Yeda Res & Dev |
Leptin assay
|
WO2001061359A2
(en)
|
2000-02-18 |
2001-08-23 |
Glaxo Group Limited |
Identification of modulators of gpr41 or gpr42 activity
|
US20110217394A1
(en)
|
2000-12-05 |
2011-09-08 |
Brett Justin West |
Iridoid Based Formulations
|
AU2002307217A1
(en)
|
2001-03-28 |
2002-10-15 |
University Of South Florida |
Materials and methods for treatment of cancer and identification of anti-cancer compounds
|
US8030008B2
(en)
|
2001-04-05 |
2011-10-04 |
Senomyx, Inc. |
Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
|
JP4360915B2
(en)
|
2002-01-07 |
2009-11-11 |
ユーロスクリーン・ソシエテ・アノニム |
G protein-coupled receptor GPR43 ligand and use thereof
|
US20030171407A1
(en)
*
|
2002-03-07 |
2003-09-11 |
Upsher-Smith Laboratories, Inc. |
Composition for reducing blood glucose and cholesterol
|
US20060019346A1
(en)
|
2002-07-29 |
2006-01-26 |
Senomyx, Inc. |
Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands
|
JP2005537298A
(en)
*
|
2002-08-02 |
2005-12-08 |
ペンウェスト ファーマシューティカルズ カンパニー |
Metformin sustained release formulation
|
AU2003282679A1
(en)
|
2002-10-04 |
2004-05-04 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
AU2003300014A1
(en)
|
2002-10-10 |
2004-05-04 |
Arena Pharmaceuticals, Inc. |
5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia
|
WO2004038421A2
(en)
|
2002-10-25 |
2004-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
|
WO2004038405A2
(en)
|
2002-10-25 |
2004-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
|
AU2003277576A1
(en)
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
CN1413582A
(en)
*
|
2002-11-29 |
2003-04-30 |
贵州圣济堂制药有限公司 |
Dimethyldiguanide hydrochloride enteric solubility tablet and its preparation method
|
DE60320682T2
(en)
|
2002-12-18 |
2009-06-10 |
Givaudan S.A. |
CHIMERIC ALPHA Q-GUSTDUCINE G PROTEINS
|
US20060160088A1
(en)
|
2003-02-17 |
2006-07-20 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 40 (gpr40)
|
DE10308504A1
(en)
|
2003-02-26 |
2004-09-09 |
Basf Ag |
Enzymatic production of (meth) acrylic acid esters
|
EP1630152A4
(en)
|
2003-05-30 |
2009-09-23 |
Takeda Pharmaceutical |
Condensed ring compound
|
EP1633351A1
(en)
|
2003-06-13 |
2006-03-15 |
Arena Pharmaceuticals, Inc. |
5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases
|
CA2532332C
(en)
|
2003-07-17 |
2007-10-02 |
Sante International, Inc. |
Dietary supplement for promoting control of blood-sugar levels and associated pathology in type 2 diabetics
|
AU2003269484A1
(en)
*
|
2003-09-11 |
2005-03-29 |
Biocon Limited |
Salt of atorvastatin with metformin
|
WO2005028488A1
(en)
|
2003-09-12 |
2005-03-31 |
Quatrx Pharmaceuticals Co. |
Heteroaryl phosphinyl and thiophosphinyl compounds for regulation of glucose, triglycerides, and ldl/hdl levels
|
TWI258478B
(en)
|
2003-10-31 |
2006-07-21 |
Arena Pharm Inc |
Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
|
US7834013B2
(en)
|
2003-11-19 |
2010-11-16 |
Glaxosmithkline Llc |
Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
|
JP2007512346A
(en)
|
2003-11-21 |
2007-05-17 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
4-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treating disorders related to their metabolism
|
BRPI0418148A
(en)
|
2003-12-25 |
2007-04-17 |
Takeda Pharmaceutical |
compound, prodrug of a compound, gpr40 receptor function modulator, pharmaceutical agent, use of a compound and methods of modifying a gpr40 receptor function in a mammal, prophylaxis or treating diabetes in a mammal and producing a compound
|
WO2005063725A1
(en)
|
2003-12-26 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
Phenylpropanoic acid derivatives
|
JP4875978B2
(en)
|
2004-03-15 |
2012-02-15 |
武田薬品工業株式会社 |
Aminophenylpropanoic acid derivatives
|
JP4859665B2
(en)
|
2004-03-30 |
2012-01-25 |
武田薬品工業株式会社 |
Alkoxyphenylpropanoic acid derivatives
|
KR20070053659A
(en)
|
2004-04-20 |
2007-05-25 |
도이체스 인스티튜트 퓌어 에른에룬그스포슝 |
Agonists of a bitter taste receptor and uses thereof
|
JP2007284350A
(en)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
Therapeutic agent for diabetes
|
US20060024335A1
(en)
|
2004-07-29 |
2006-02-02 |
Roger Stier E |
Oral compositions which mask the bitter taste of a bitter-tasting agent
|
SG155896A1
(en)
|
2004-09-22 |
2009-10-29 |
Arena Pharm Inc |
Gpr43 and modulators thereof for the treatment of metabolic-related disorders
|
JPWO2006038738A1
(en)
|
2004-10-08 |
2008-05-15 |
武田薬品工業株式会社 |
Receptor function regulator
|
US20080312277A1
(en)
|
2004-11-03 |
2008-12-18 |
Leonard James N |
Gpr41 and Modulators Thereof for the Treatment of Insulin-Related Disorders
|
EP1815015B1
(en)
|
2004-11-18 |
2012-05-23 |
Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke Stiftung des Öffentlichen Rechts |
Agonists of bitter taste receptors and uses thereof
|
PE20060949A1
(en)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
FUSED DERIVATIVES OF PIRAZOLE AS NIACIN RECEPTOR AGONISTS
|
DOP2006000008A
(en)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
|
CA2593788A1
(en)
|
2005-01-28 |
2006-08-10 |
Merck And Co., Inc. |
Antidiabetic bicyclic compounds
|
CA2593858A1
(en)
|
2005-01-31 |
2006-08-10 |
Min Ge |
Antidiabetic bicyclic compounds
|
US20060222709A1
(en)
*
|
2005-03-18 |
2006-10-05 |
Agi Therapeutics Research Ltd. |
Metformin methods and formulations for treating chronic constipation
|
WO2006102653A2
(en)
|
2005-03-24 |
2006-09-28 |
Irm Llc |
Methods and compositions for treating insulin resistance and obesity-induced diseases
|
AU2006241684A1
(en)
|
2005-04-28 |
2006-11-09 |
Ajinomoto Co., Inc. |
Novel lactam compound
|
EP1899304A1
(en)
|
2005-05-23 |
2008-03-19 |
Arena Pharmaceuticals, Inc. |
5-amino-1h-pyrazole-3-carboxylic acid derivatives as agonists for the g-protein coupled receptor (gpcr) rup38 for the treatment of metabolic-related disorders thereof
|
US20060269617A1
(en)
|
2005-05-26 |
2006-11-30 |
Suracell, Inc. |
Supplement compositions and method of use for enhancement of insulin sensitivity
|
WO2007002026A2
(en)
|
2005-06-22 |
2007-01-04 |
Senomyx, Inc. |
Identification of human t2r recepors that are activated by bitter molecules in coffee (chlorogenic lactones) and related assays for identifying human bitter taste modulators
|
US20080299270A1
(en)
|
2005-07-28 |
2008-12-04 |
Nestec S.A. |
Fat Taste Receptors and Their Methods of Use
|
JP5084503B2
(en)
|
2005-07-29 |
2012-11-28 |
武田薬品工業株式会社 |
Cyclopropanecarboxylic acid compound
|
US20090117559A1
(en)
|
2005-08-10 |
2009-05-07 |
Liaw Chen W |
Methods for Determining Probability of an Adverse or Favorable Reaction to a Niacin Receptor Agonist
|
JP4932724B2
(en)
|
2005-09-02 |
2012-05-16 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
Screening method of substances useful for diseases using GPR120 and phospholipase
|
WO2007049050A2
(en)
|
2005-10-27 |
2007-05-03 |
Heptahelix Ab |
Modulators of gpr40 for the treatment of diabetes
|
US20070104805A1
(en)
|
2005-11-01 |
2007-05-10 |
Udell Ronald G |
Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
|
JP2007215162A
(en)
|
2006-01-11 |
2007-08-23 |
Canon Inc |
Information processing apparatus, control method thereof, program and recording medium
|
US20070207227A1
(en)
|
2006-02-23 |
2007-09-06 |
Conopco, Inc., D/B/A Unilever, A Corporation Of New York |
Appetite suppressant compositions
|
BRPI0710839A2
(en)
|
2006-04-06 |
2011-08-23 |
Prosidion Ltd |
heterocyclic gpcr agonists
|
WO2007116404A2
(en)
|
2006-04-10 |
2007-10-18 |
Bar-Ilan University |
Cucurbitacin glucosides and use thereof in treating cancer
|
CL2007001011A1
(en)
|
2006-04-11 |
2008-05-16 |
Arena Pharm Inc |
METHOD FOR THE IDENTIFICATION OF GIP SECRETAGOGS, GASTRIC INHIBITOR POLYPEPTIDE; AND USE OF A PROTEIN G COUPLED RECEIVER TO CLASSIFY TEST COMPOUNDS AS GIP SECRETAGOGS.
|
GB0607196D0
(en)
|
2006-04-11 |
2006-05-17 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
PE20071221A1
(en)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
|
TW200815377A
(en)
|
2006-04-24 |
2008-04-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
AU2007254325B2
(en)
|
2006-05-15 |
2012-05-10 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2007134613A1
(en)
|
2006-05-24 |
2007-11-29 |
Rheoscience A/S |
Modulation of gpr120 activity in adipocytes/fat tissue
|
CA2551706A1
(en)
|
2006-06-27 |
2007-12-27 |
Innovative Life Sciences Corporation |
Herbal product comprising cinnamon and bitter melon
|
RS52307B
(en)
|
2006-06-27 |
2012-12-31 |
Takeda Pharmaceutical Company Limited |
Fused cyclic compounds
|
CN100596277C
(en)
|
2006-07-10 |
2010-03-31 |
博仲盛景医药技术(北京)有限公司 |
Medicinal composition for promoting enterogastric peristalsis
|
WO2008008887A2
(en)
|
2006-07-13 |
2008-01-17 |
Smithkline Beecham Corporation |
Gpr119 agonists for treating metabolic disorders
|
AP2518A
(en)
|
2006-08-17 |
2012-11-28 |
Unilever Plc |
Processes for production of hoodia plant extracts containing steroidal glycosides
|
CA2661593A1
(en)
|
2006-08-24 |
2008-02-28 |
Unilever Plc |
Process for preparing a composition comprising steroidal glycosides
|
WO2008025799A1
(en)
|
2006-08-30 |
2008-03-06 |
Biovitrum Ab (Publ) |
Pyridazine compounds for treating gpr119 related disorders
|
CN101522702A
(en)
|
2006-09-05 |
2009-09-02 |
塞诺米克斯公司 |
Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators
|
US7714008B2
(en)
|
2006-09-07 |
2010-05-11 |
Amgen Inc. |
Heterocyclic GPR40 modulators
|
WO2008063321A2
(en)
|
2006-10-13 |
2008-05-29 |
Janssen Pharmaceutica N.V. |
Gpr81-ligand complexes and their preparation and use
|
WO2008054674A2
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
CA2667249A1
(en)
|
2006-10-31 |
2008-05-08 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
WO2008058355A2
(en)
*
|
2006-11-16 |
2008-05-22 |
Walter Santos Junior |
Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases
|
BRMU8602999U
(en)
*
|
2006-11-16 |
2008-07-08 |
Walter Junior Santos |
medicine "rosuvastatin + metformin" in combination form for cardiovascular disease
|
CN101190179B
(en)
*
|
2006-11-20 |
2010-05-12 |
北京利龄恒泰药业有限公司 |
Enteric medicinal composition for treating diabetes and preparation method thereof
|
US8367708B2
(en)
|
2006-12-01 |
2013-02-05 |
Msd K.K. |
Phenyl-isoxazol-3-ol derivative
|
TW200838526A
(en)
|
2006-12-01 |
2008-10-01 |
Astellas Pharma Inc |
Carboxylic acid derivatives
|
EP2109447B1
(en)
*
|
2007-01-29 |
2015-06-10 |
HanAll Biopharma Co., Ltd. |
N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
AU2008218950A1
(en)
|
2007-02-22 |
2008-08-28 |
Irm Llc |
Thiazole derivatives as modulators of G protein-coupled receptors
|
ATE482209T1
(en)
|
2007-03-08 |
2010-10-15 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
|
EP1975611A1
(en)
|
2007-03-29 |
2008-10-01 |
Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand |
Agonists of bitter taste receptors and uses thereof
|
EP1975612A1
(en)
|
2007-03-29 |
2008-10-01 |
Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand |
Agonists of bitter taste receptors and uses thereof
|
WO2008130514A1
(en)
|
2007-04-16 |
2008-10-30 |
Amgen Inc. |
Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
|
MX2009011357A
(en)
|
2007-04-20 |
2009-11-05 |
Schering Corp |
Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof.
|
CA2684634A1
(en)
|
2007-04-20 |
2008-10-30 |
Schering Corporation |
Pyrimidinone derivatives and methods of use thereof
|
US20100190687A1
(en)
|
2007-04-20 |
2010-07-29 |
Boyle Craig D |
Pyrimidinone derivatives and methods of use thereof
|
WO2008139987A1
(en)
|
2007-04-26 |
2008-11-20 |
Japan Science And Technology Agency |
G-protein-conjugated receptor agonist
|
ES2388315T3
(en)
|
2007-05-04 |
2012-10-11 |
Bristol-Myers Squibb Company |
[6.5] -Gyccyclic GPR119 receptor agonists coupled to G protein
|
PE20090222A1
(en)
|
2007-05-04 |
2009-03-27 |
Bristol Myers Squibb Co |
[6,6] AND [6,7] -BICYCLIC COMPOUNDS AS AGONISTS OF THE RECEPTOR COUPLED TO PROTEIN G GPR119
|
WO2008144423A2
(en)
|
2007-05-15 |
2008-11-27 |
Medical College Of Georgia Research Institute, Inc. |
Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer
|
PE20090449A1
(en)
|
2007-07-17 |
2009-04-18 |
Bristol Myers Squibb Co |
PIRIDONE PROTEIN G GPR119-COUPLED RECEPTOR AGONISTS
|
KR20100033419A
(en)
|
2007-07-19 |
2010-03-29 |
메타볼렉스, 인코포레이티드 |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders
|
US20090042813A1
(en)
|
2007-08-10 |
2009-02-12 |
Sergey Michailovich Melnikov |
Hoodia extract oil compositions comprising medium chain triglycerides
|
WO2009033072A1
(en)
|
2007-09-05 |
2009-03-12 |
Raif Tawakol |
Compositions and methods for controlling cholesterol levels
|
EP2200609A1
(en)
|
2007-09-10 |
2010-06-30 |
Prosidion Limited |
Compounds for the treatment of metabolic disorders
|
WO2009038204A1
(en)
|
2007-09-17 |
2009-03-26 |
Pharma Frontier Co., Ltd. |
Novel long-chain fatty acid derivative compound and g-protein-coupled receptor agonist containing the compound as active ingredient
|
BRPI0817211A2
(en)
|
2007-09-20 |
2017-05-16 |
Irm Llc |
compound compositions as modulators of gpr119 activity
|
WO2009048527A1
(en)
|
2007-10-10 |
2009-04-16 |
Amgen Inc. |
Substituted biphenyl gpr40 modulators
|
GB0720390D0
(en)
|
2007-10-18 |
2007-11-28 |
Prosidion Ltd |
G-Protein coupled receptor agonists
|
GB0720389D0
(en)
|
2007-10-18 |
2008-11-12 |
Prosidion Ltd |
G-Protein Coupled Receptor Agonists
|
CN101910151A
(en)
|
2007-10-22 |
2010-12-08 |
先灵公司 |
Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
|
JP2011016722A
(en)
|
2007-10-23 |
2011-01-27 |
Astellas Pharma Inc |
Thiazolidinedione compound
|
TW200932219A
(en)
|
2007-10-24 |
2009-08-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
WO2009053980A2
(en)
|
2007-10-24 |
2009-04-30 |
Arava Hoodia Growers A. C. S. Ltd. |
An improved appetite suppressant
|
AU2008319418B2
(en)
|
2007-10-29 |
2013-08-15 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
DK2236149T3
(en)
|
2008-01-29 |
2014-08-25 |
Nakamori Pharmaceutical Co Ltd |
Medical composition for the treatment of respiratory infectious diseases
|
BRPI0907584A2
(en)
|
2008-02-22 |
2015-07-21 |
Irm Llc |
Compound and compositions as gpr119 activity modulators
|
CA2716332A1
(en)
|
2008-02-22 |
2009-08-27 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
AU2009217361A1
(en)
|
2008-02-22 |
2009-08-27 |
Irm Llc |
Compounds and compositions as modulators of GPR119 activity
|
WO2009106561A1
(en)
|
2008-02-27 |
2009-09-03 |
Biovitrum Ab (Publ) |
Pyrazine compounds for treating gpr119 related disorders
|
WO2009106565A1
(en)
|
2008-02-27 |
2009-09-03 |
Biovitrum Ab (Publ) |
Agonists of gpr119
|
WO2009117421A2
(en)
|
2008-03-17 |
2009-09-24 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
BRPI0909469A2
(en)
|
2008-03-31 |
2015-12-29 |
Metabolex Inc |
aryl oxymethylene compounds and uses thereof
|
JP2011516557A
(en)
|
2008-04-07 |
2011-05-26 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Compounds and compositions as modulators of GPR119 activity
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
WO2009125804A1
(en)
|
2008-04-09 |
2009-10-15 |
武田薬品工業株式会社 |
Screening method
|
US8188098B2
(en)
|
2008-05-19 |
2012-05-29 |
Hoffmann-La Roche Inc. |
GPR119 receptor agonists
|
WO2009143049A1
(en)
|
2008-05-19 |
2009-11-26 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
EP2306851B1
(en)
|
2008-05-23 |
2012-08-01 |
Givaudan SA |
Bitter alkaloid containing consumables comprising bitter blockers
|
WO2009151542A2
(en)
|
2008-05-27 |
2009-12-17 |
Duke University |
Nicotinic acid receptor ligands
|
CN101695575A
(en)
*
|
2008-05-29 |
2010-04-21 |
北京奥萨医药研究中心有限公司 |
Pharmaceutical composition containing statin-type lipid-lowering medicaments, phenformin-type hypoglycemic medicaments and nicotinic acid
|
JPWO2009147990A1
(en)
|
2008-06-02 |
2011-10-27 |
Msd株式会社 |
New isoxazole derivatives
|
WO2009150144A1
(en)
|
2008-06-10 |
2009-12-17 |
Inovacia Ab |
New gpr119modulators
|
WO2009149577A1
(en)
|
2008-06-13 |
2009-12-17 |
Givaudan Sa |
Methods of identifying modulators of the bitter taste receptor tas2r44
|
JP2011524917A
(en)
|
2008-06-20 |
2011-09-08 |
メタボレックス, インコーポレイテッド |
Aryl GPR119 agonists and uses thereof
|
GB0812031D0
(en)
|
2008-07-01 |
2008-08-06 |
7Tm Pharma As |
Thiazole derivatives
|
GB0812648D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
GB0812649D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
CA2730511C
(en)
|
2008-07-11 |
2013-06-11 |
Robert Epple |
4-phenoxymethylpiperidines as modulators of gpr119 activity
|
TW201006821A
(en)
|
2008-07-16 |
2010-02-16 |
Bristol Myers Squibb Co |
Pyridone and pyridazone analogues as GPR119 modulators
|
JP2011528365A
(en)
|
2008-07-16 |
2011-11-17 |
シェーリング コーポレイション |
Bicyclic heterocyclic derivatives as GPR119 modulators and methods for their use
|
WO2010012650A1
(en)
|
2008-07-28 |
2010-02-04 |
Syddansk Universitet |
Compounds for the treatment of metabolic diseases
|
WO2010013849A1
(en)
|
2008-08-01 |
2010-02-04 |
日本ケミファ株式会社 |
Gpr119 agonist
|
US8901166B2
(en)
|
2008-08-29 |
2014-12-02 |
Suntory Holdings Limited |
Epigallocatechin gallate tetramer and vascular endothelial function improving agent containing the same
|
EP2329271B1
(en)
|
2008-08-29 |
2012-06-20 |
Givaudan SA |
Methods to identify modulators
|
EP2344195A2
(en)
|
2008-09-10 |
2011-07-20 |
Boehringer Ingelheim International GmbH |
Combination therapy for the treatment of diabetes and related conditions
|
WO2010030360A1
(en)
|
2008-09-11 |
2010-03-18 |
Arena Pharmaceuticals, Inc. |
3H-IMIDAZO[4,5-b]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS
|
US8748462B2
(en)
|
2008-10-15 |
2014-06-10 |
Amgen Inc. |
Spirocyclic GPR40 modulators
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
KR20110082145A
(en)
|
2008-10-21 |
2011-07-18 |
메타볼렉스, 인코포레이티드 |
Aryl gpr120 receptor agonists and uses thereof
|
WO2010060198A1
(en)
|
2008-11-26 |
2010-06-03 |
West Central Envirotech Inc. |
Composition and method for controlling insects
|
AR074760A1
(en)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
GPR120 RECEIVER AGONISTS AND USES OF THE SAME IN MEDICINES FOR THE TREATMENT OF DIABETES AND METABOLIC SYNDROME.
|
WO2010074271A1
(en)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
Therapeutic agent for diabetes
|
WO2010076879A1
(en)
|
2009-01-03 |
2010-07-08 |
静岡県公立大学法人 |
Sulfated c-glycoside, method for isolating same and method for synthesizing same
|
JPWO2010084944A1
(en)
|
2009-01-22 |
2012-07-19 |
田辺三菱製薬株式会社 |
Novel pyrrolo [2,3-d] pyrimidine compounds
|
CA2749930A1
(en)
|
2009-01-23 |
2010-07-29 |
Schering Corporation |
Bridged and fused heterocyclic antidiabetic compounds
|
JP2012515782A
(en)
|
2009-01-23 |
2012-07-12 |
シェーリング コーポレイション |
Antidiabetic crosslinking and condensation compounds
|
CA2749663A1
(en)
|
2009-01-23 |
2010-07-29 |
Hubert B. Josien |
Pentafluorosulpholane-containing antidiabetic compounds
|
WO2010088518A2
(en)
|
2009-01-31 |
2010-08-05 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
US8575166B2
(en)
|
2009-02-05 |
2013-11-05 |
Merck Sharp & Dohme Corp. |
Phthalazine-containing antidiabetic compounds
|
US8410089B2
(en)
|
2009-02-18 |
2013-04-02 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic ring compound
|
GB0904287D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
GB0904285D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
GB0904284D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
US20120095028A1
(en)
|
2009-03-20 |
2012-04-19 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
JP2012136438A
(en)
|
2009-04-22 |
2012-07-19 |
Astellas Pharma Inc |
Tetrazole compound
|
JPWO2010123016A1
(en)
|
2009-04-22 |
2012-10-25 |
アステラス製薬株式会社 |
Carboxylic acid compound
|
JP2012136439A
(en)
|
2009-04-24 |
2012-07-19 |
Nippon Chemiphar Co Ltd |
Diazaspiroalkane derivative
|
JP2012526097A
(en)
|
2009-05-08 |
2012-10-25 |
ファイザー・インク |
GPR119 regulator
|
US20120052130A1
(en)
|
2009-05-08 |
2012-03-01 |
Pfizer Inc. |
Gpr 119 modulators
|
GEP20135907B
(en)
|
2009-06-05 |
2013-08-12 |
Pfizer |
L-(piperidin-4-yl)-pyrazole derivatives as gpr 119 modulators
|
EP2440541A1
(en)
|
2009-06-09 |
2012-04-18 |
Takeda Pharmaceutical Company Limited |
Novel fused cyclic compound and use thereof
|
AR077642A1
(en)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME
|
AR077638A1
(en)
|
2009-07-15 |
2011-09-14 |
Lilly Co Eli |
COMPOSITE OF (METHANOSULPHONYL -PIPERIDIN) - (ALCOXI-ARIL) -TETRAHIDRO- PYRIDINE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF DIABETES OR OBESITY
|
WO2011012298A1
(en)
|
2009-07-28 |
2011-02-03 |
Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke |
Agonists and antagonists of human bitter taste receptor tas2r49 and uses thereof
|
WO2011014520A2
(en)
|
2009-07-29 |
2011-02-03 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
EP2474540A4
(en)
|
2009-08-31 |
2013-03-13 |
Nippon Chemiphar Co |
Gpr119 agonist
|
BR112012004677A2
(en)
|
2009-09-01 |
2020-11-03 |
Catabasis Pharmaceuticals, Inc. |
niacin fatty acid conjugates and their uses
|
WO2011030139A1
(en)
|
2009-09-11 |
2011-03-17 |
Astrazeneca Ab |
4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators
|
CA2772188A1
(en)
|
2009-09-23 |
2011-03-31 |
Pfizer Inc. |
Gpr 119 modulators
|
US20110082156A1
(en)
|
2009-10-05 |
2011-04-07 |
Milne Jill C |
Fatty acid acipimox derivatives and their uses
|
US20110082202A1
(en)
|
2009-10-05 |
2011-04-07 |
Milne Jill C |
Fatty acid acifran derivatives and their uses
|
BR112012007979A2
(en)
|
2009-10-06 |
2016-03-29 |
Bristol Myers Squibb Co |
pyrrolidine gpr40 modulators
|
KR20120092629A
(en)
|
2009-10-09 |
2012-08-21 |
아이알엠 엘엘씨 |
Compounds and compositions as modulators of gpr119 activity
|
EP2488180A4
(en)
*
|
2009-10-12 |
2013-03-27 |
Ipca Lab Ltd |
Pharmaceutical compositions for the treatment/prophylaxis of non-alcoholic fatty liver disease
|
ES2437921T3
(en)
|
2009-10-21 |
2014-01-15 |
Wisconsin Alumni Research Foundation |
Method to prevent type 1 diabetes
|
CA2778684A1
(en)
|
2009-10-29 |
2011-05-05 |
Schering Corporation |
Bridged bicyclic piperidine derivatives and methods of use thereof
|
WO2011052756A1
(en)
|
2009-10-30 |
2011-05-05 |
持田製薬株式会社 |
Novel 3-hydroxy-5-arylisoxazole derivative
|
WO2011057110A1
(en)
|
2009-11-06 |
2011-05-12 |
Ruprecht-Karls-Universitat-Heidelberg |
Gpr109a agonists for the treatment of cerebral ischemia
|
JPWO2011055770A1
(en)
|
2009-11-06 |
2013-03-28 |
武田薬品工業株式会社 |
Fused heterocyclic compounds
|
EP2504342A1
(en)
|
2009-11-23 |
2012-10-03 |
Pfizer Inc. |
Imidazo-pyrazoles as gpr119 inhibitors
|
US9301929B2
(en)
|
2009-11-24 |
2016-04-05 |
Merck Sharp & Dohme Corp. |
Substituted biaryl derivatives and methods of use thereof
|
BR112012013469A2
(en)
|
2009-12-04 |
2016-05-17 |
Colgate Palmolive Co |
oral compositions containing extracts of garcinia mangostana l. and related methods
|
EP2332427A1
(en)
|
2009-12-07 |
2011-06-15 |
Nestec S.A. |
low caloric fat replacers
|
WO2011072132A1
(en)
|
2009-12-09 |
2011-06-16 |
The Regents Of The University Of California |
Methods of treating inflammatory conditions
|
WO2011073376A1
(en)
|
2009-12-18 |
2011-06-23 |
Euroscreen S.A. |
Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disordersas as agonists of g- protein coupled receptor 43 (gpr43)
|
JP2013047188A
(en)
|
2009-12-24 |
2013-03-07 |
Nippon Chemiphar Co Ltd |
Gpr119 agonist
|
BR112012015612A2
(en)
|
2009-12-25 |
2016-03-15 |
Mochida Pharm Co Ltd |
new 3-hydroxy-5-arylisothiazole derivative
|
EP2345646A1
(en)
|
2010-01-14 |
2011-07-20 |
InterMed Discovery GmbH |
Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
|
WO2011092284A1
(en)
|
2010-01-29 |
2011-08-04 |
Euroscreen S.A. |
Novel amino acid derivatives and their use as gpr43 receptor modulators
|
EP2532656A1
(en)
|
2010-02-01 |
2012-12-12 |
Nippon Chemiphar Co., Ltd. |
Gpr119 agonist
|
CN101785763B
(en)
*
|
2010-02-04 |
2011-11-23 |
贵州天安药业股份有限公司 |
Metformin hydrochloride enteric-coated sustained release tablet and preparation method thereof
|
US20130109703A1
(en)
|
2010-03-18 |
2013-05-02 |
Boehringer Ingelheim International Gmbh |
Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions
|
BR112012025592A2
(en)
|
2010-04-06 |
2019-09-24 |
Arena Pharm Inc |
gpr119 receptor modulators and the treatment of disorders related thereto
|
MX2012011460A
(en)
|
2010-04-08 |
2012-11-23 |
Squibb Bristol Myers Co |
Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators.
|
GB201006166D0
(en)
|
2010-04-14 |
2010-05-26 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
GB201006167D0
(en)
|
2010-04-14 |
2010-05-26 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
MX2012012902A
(en)
|
2010-05-06 |
2012-12-17 |
Bristol Myers Squibb Co |
Bicyclic heteroaryl compounds as gpr119 modulators.
|
US8729084B2
(en)
|
2010-05-06 |
2014-05-20 |
Bristol-Myers Squibb Company |
Benzofuranyl analogues as GPR119 modulators
|
EP2566864B1
(en)
|
2010-05-07 |
2014-09-03 |
Boehringer Ingelheim International GmbH |
Pyridazinones as gpr119 agonists
|
MX2012013465A
(en)
|
2010-05-17 |
2013-12-02 |
Array Biopharma Inc |
Piperidinyl-substituted lactams as gpr119 modulators.
|
WO2011145718A1
(en)
|
2010-05-21 |
2011-11-24 |
田辺三菱製薬株式会社 |
Novel pyrrolo[2,3-d]pyrimidine compound
|
TW201202230A
(en)
|
2010-05-24 |
2012-01-16 |
Mitsubishi Tanabe Pharma Corp |
Novel quinazoline compound
|
TW201209054A
(en)
|
2010-05-28 |
2012-03-01 |
Prosidion Ltd |
Novel compounds
|
US20110293753A1
(en)
|
2010-05-28 |
2011-12-01 |
Louis Bellafiore |
Tocotrienol Compositions
|
WO2011151436A2
(en)
|
2010-06-04 |
2011-12-08 |
Euroscreen S.A. |
Novel compounds, method for use them and pharmaceutical composition containing them
|
GB201009873D0
(en)
|
2010-06-14 |
2010-07-21 |
Univ Leuven Kath |
Method for hydrogenation of isoalpha-acids (isohumulones) to hexahydro-iso-alpha-acids (hexahydro-isohumulones) by using heterogeneous ruthenium
|
CA2801182A1
(en)
|
2010-06-16 |
2011-12-22 |
Metabolex, Inc. |
Gpr120 receptor agonists and uses thereof
|
US20130096141A1
(en)
|
2010-06-18 |
2013-04-18 |
Bernard R. Neustadt |
Bicyclic heterocycle derivatives and methods of use thereof
|
EP2397039A1
(en)
|
2010-06-21 |
2011-12-21 |
Abbott Laboratories |
Compositions for delaying progression of diabetes using Salacia oblonga extract
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
WO2012006955A1
(en)
|
2010-07-14 |
2012-01-19 |
Zhejiang Beta Pharma Inc. |
Compounds for treatment of metabolic disorders
|
MA34474B1
(en)
|
2010-07-23 |
2013-08-01 |
Connexios Life Sciences Pvt Ltd |
AGONISTS OF GPR40
|
KR20120011357A
(en)
|
2010-07-23 |
2012-02-08 |
현대약품 주식회사 |
Substituted pyridinone derivatives and methods for manufacturing the same
|
WO2012025811A1
(en)
|
2010-08-23 |
2012-03-01 |
Lupin Limited |
Indolylpyrimidines as modulators of gpr119
|
JP2013537234A
(en)
|
2010-09-17 |
2013-09-30 |
アレイ バイオファーマ、インコーポレイテッド |
Piperidinyl-substituted lactams as GPR119 modulators
|
SG188548A1
(en)
|
2010-09-22 |
2013-04-30 |
Arena Pharm Inc |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
CN102432598A
(en)
|
2010-09-29 |
2012-05-02 |
江苏恒瑞医药股份有限公司 |
Tricyclic compound, preparation method thereof and pharmaceutical application thereof
|
JP2014001144A
(en)
|
2010-10-08 |
2014-01-09 |
Nippon Chemiphar Co Ltd |
Gpr119 agonist
|
KR101563793B1
(en)
|
2010-10-08 |
2015-10-27 |
카딜라 핼쓰캐어 리미티드 |
Novel gpr 119 agonists
|
US9040525B2
(en)
|
2010-10-08 |
2015-05-26 |
Mochida Pharmaceutical Co., Ltd. |
Cyclic amide derivative
|
CN101978956B
(en)
*
|
2010-10-13 |
2012-03-28 |
北京京丰制药有限公司 |
Metformin hydrochloride enteric-coated tablets and preparation method thereof
|
AU2011320140C1
(en)
|
2010-10-30 |
2019-12-12 |
Kindex Pharmaceuticals, Inc. |
Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(-3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
|
BR112013011865A2
(en)
|
2010-11-23 |
2016-08-23 |
Pfizer |
gpr119 modulators
|
EP2643311A1
(en)
|
2010-11-26 |
2013-10-02 |
Lupin Limited |
Bicyclic gpr119 modulators
|
AR084050A1
(en)
|
2010-12-01 |
2013-04-17 |
Boehringer Ingelheim Int |
INDANILOXIDIHIDROBENZOFURANILACETIC ACIDS
|
WO2012077655A1
(en)
|
2010-12-07 |
2012-06-14 |
塩野義製薬株式会社 |
Spiro derivative having gpr119 agonist activity
|
UY33805A
(en)
|
2010-12-17 |
2012-07-31 |
Boehringer Ingelheim Int |
? Dihydrobenzofuranyl-piperidinyl, aza-dihydrobenzofuranylpiperidinyl and diaza-dihydrobenzofuranyl-piperidinyl derivatives, pharmaceutical compositions containing them and uses thereof?
|
WO2012093809A2
(en)
|
2011-01-03 |
2012-07-12 |
Hanmi Pharm Co., Ltd. |
New bicyclic compound for modulating g protein-coupled receptors
|
WO2012098217A1
(en)
|
2011-01-21 |
2012-07-26 |
Boehringer Ingelheim International Gmbh |
Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
|
CN102617548A
(en)
|
2011-01-31 |
2012-08-01 |
北京赛林泰医药技术有限公司 |
Bicycloheteroaryl compounds as GPR Receptor stimulant, compositions and application thereof
|
TW201309639A
(en)
|
2011-02-17 |
2013-03-01 |
Lg Life Sciences Ltd |
Oxime derivatives as GPR119 agonists
|
JP5935154B2
(en)
|
2011-03-14 |
2016-06-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
N-cyclopropyl-N-piperidinylbenzamide as a GPR119 modulator
|
US20140018371A1
(en)
|
2011-04-01 |
2014-01-16 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
EP2694465A4
(en)
|
2011-04-08 |
2015-03-18 |
Univ Syddansk |
Ortho-fluoro substituted compounds for the treatment of metabolic diseases
|
US20140066369A1
(en)
|
2011-04-19 |
2014-03-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145604A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US20140038889A1
(en)
|
2011-04-22 |
2014-02-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
EP2703394A4
(en)
|
2011-04-27 |
2014-11-05 |
Mochida Pharm Co Ltd |
Novel 3-hydroxyisothiazole 1-oxide derivative
|
CA2834465A1
(en)
|
2011-04-28 |
2012-11-01 |
Mochida Pharmaceutical Co., Ltd. |
Cyclic amide derivative
|
WO2012154009A2
(en)
|
2011-05-12 |
2012-11-15 |
한국화학연구원 |
Thienopyrimidine derivatives, pharmaceutically acceptable salts thereof, method for preparing thienopyrimidine derivatives, and pharmaceutical composition containing thienopyrimidine derivatives as active ingredients for preventing or treating diabetes-related diseases
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
JP6094578B2
(en)
|
2011-06-09 |
2017-03-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Substituted piperidines as GPR119 modulators for the treatment of metabolic disorders
|
JP2014159376A
(en)
|
2011-06-17 |
2014-09-04 |
Taisho Pharmaceutical Co Ltd |
Azaspiroalkane compound
|
WO2013011402A1
(en)
|
2011-07-15 |
2013-01-24 |
Pfizer Inc. |
Gpr 119 modulators
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
CN102357088A
(en)
*
|
2011-10-26 |
2012-02-22 |
河北山姆士药业有限公司 |
Metformin hydrochloride enteric-coated tablet
|